REPLIMUNE GROUP, INC. Financing Cash Flow
REPLIMUNE GROUP, INC. (REPL) reported Financing Cash Flow of $800.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- REPLIMUNE GROUP, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $800.00K.
- REPLIMUNE GROUP, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $55.68M.
- REPLIMUNE GROUP, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $10.45M, a 93.30% decline year-over-year.
- REPLIMUNE GROUP, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $324.00K.
- REPLIMUNE GROUP, INC. net cash provided by (used in) financing activities for fiscal 2026 was $66.29M, a 73.73% decline from fiscal 2025.
- REPLIMUNE GROUP, INC. net cash provided by (used in) financing activities for fiscal 2025 was $252.40M, a 1450.06% increase from fiscal 2024.
- REPLIMUNE GROUP, INC. net cash provided by (used in) financing activities for fiscal 2024 was $16.28M, a 94.77% decline from fiscal 2023.
- REPLIMUNE GROUP, INC. net cash provided by (used in) financing activities for fiscal 2023 was $311.30M, a 4618.14% increase from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $800.00K 10-Q · filed 2026-08-14 | $56.48M derived: sum of 2 quarters · filed 2026-08-14 | $66.93M derived: sum of 3 quarters · filed 2026-08-14 | $67.25M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $55.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $66.13M derived: sum of 2 quarters · filed 2026-06-29 | $66.45M derived: sum of 3 quarters · filed 2026-06-29 | $66.29M 10-K · filed 2026-06-29 |
| 2025-12-31 | $10.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-03 | $10.78M derived: sum of 2 quarters · filed 2026-02-03 | $10.62M 10-Q · filed 2026-02-03 | $10.48M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | $324.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $166.00K 10-Q · filed 2025-11-06 | $34.00K derived: sum of 3 quarters · filed 2026-08-14 | $155.96M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$158.00K 10-Q · filed 2026-08-14 | -$290.00K derived: sum of 2 quarters · filed 2026-08-14 | $155.64M derived: sum of 3 quarters · filed 2026-08-14 | $155.60M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $155.80M derived: sum of 2 quarters · filed 2026-06-29 | $155.76M derived: sum of 3 quarters · filed 2026-06-29 | $252.40M 10-K · filed 2026-06-29 |
| 2024-12-31 | $155.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-03 | $155.89M derived: sum of 2 quarters · filed 2026-02-03 | $252.53M 10-Q · filed 2026-02-03 | $252.40M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | -$39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $96.60M 10-Q · filed 2025-11-06 | $96.47M derived: sum of 3 quarters · filed 2025-11-06 | $111.34M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $96.64M 10-Q · filed 2025-08-07 | $96.51M derived: sum of 2 quarters · filed 2025-08-07 | $111.38M derived: sum of 3 quarters · filed 2025-08-07 | $111.81M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | $14.74M derived: sum of 2 quarters · filed 2025-05-22 | $15.18M derived: sum of 3 quarters · filed 2025-05-22 | $16.28M 10-K · filed 2025-05-22 |
| 2023-12-31 | $14.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-12 | $15.31M derived: sum of 2 quarters · filed 2025-02-12 | $16.41M 10-Q · filed 2025-02-12 | $16.34M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $438.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-12 | $1.54M 10-Q · filed 2024-11-12 | $1.47M derived: sum of 3 quarters · filed 2024-11-12 | $272.90M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.10M 10-Q · filed 2024-08-08 | $1.03M derived: sum of 2 quarters · filed 2024-08-08 | $272.46M derived: sum of 3 quarters · filed 2024-08-08 | $279.89M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | $271.36M derived: sum of 2 quarters · filed 2024-05-16 | $278.78M derived: sum of 3 quarters · filed 2024-05-16 | $311.30M 10-K · filed 2024-05-16 |
| 2022-12-31 | $271.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $278.86M derived: sum of 2 quarters · filed 2024-02-08 | $311.38M 10-Q · filed 2024-02-08 | $311.74M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | $7.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-07 | $39.95M 10-Q · filed 2023-11-07 | $40.30M derived: sum of 3 quarters · filed 2023-11-07 | $44.27M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $32.52M 10-Q · filed 2023-08-03 | $32.88M derived: sum of 2 quarters · filed 2023-08-03 | $36.85M derived: sum of 3 quarters · filed 2023-08-03 | $38.00M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-18 | $4.33M derived: sum of 2 quarters · filed 2023-05-18 | $5.48M derived: sum of 3 quarters · filed 2023-05-18 | $6.60M 10-K · filed 2023-05-18 |
| 2021-12-31 | $3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | $5.12M derived: sum of 2 quarters · filed 2023-02-09 | $6.24M 10-Q · filed 2023-02-09 | $7.02M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-03 | $2.27M 10-Q · filed 2022-11-03 | $3.06M derived: sum of 3 quarters · filed 2022-11-03 | $265.25M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $1.12M 10-Q · filed 2022-08-04 | $1.91M derived: sum of 2 quarters · filed 2022-08-04 | $264.10M derived: sum of 3 quarters · filed 2022-08-04 | $264.07M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $785.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-19 | $262.98M derived: sum of 2 quarters · filed 2022-05-19 | $262.95M derived: sum of 3 quarters · filed 2022-05-19 | $372.46M 10-K · filed 2022-05-19 |
| 2020-12-31 | $262.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-03 | $262.16M derived: sum of 2 quarters · filed 2022-02-03 | $371.68M 10-Q · filed 2022-02-03 | $371.71M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-09-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-04 | $109.48M 10-Q · filed 2021-11-04 | $109.51M derived: sum of 3 quarters · filed 2021-11-04 | $199.88M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $109.51M 10-Q · filed 2021-08-06 | $109.55M derived: sum of 2 quarters · filed 2021-08-06 | $199.91M derived: sum of 3 quarters · filed 2021-08-06 | $209.66M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-20 | $90.40M derived: sum of 2 quarters · filed 2021-05-20 | $100.15M derived: sum of 3 quarters · filed 2021-05-20 | $100.17M 10-K · filed 2021-05-20 |
| 2019-12-31 | $90.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-04 | $100.11M derived: sum of 2 quarters · filed 2021-02-04 | $100.13M 10-Q · filed 2021-02-04 | $100.17M derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-09-30 | $9.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05 | $9.77M 10-Q · filed 2020-11-05 | $9.81M derived: sum of 3 quarters · filed 2020-11-05 | $9.96M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $18.00K 10-Q · filed 2020-08-07 | $59.00K derived: sum of 2 quarters · filed 2020-08-07 | $212.00K derived: sum of 3 quarters · filed 2020-08-07 | $101.60M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | $194.00K derived: sum of 2 quarters · filed 2020-06-03 | $101.58M derived: sum of 3 quarters · filed 2020-06-03 | $101.39M 10-K · filed 2020-06-03 |
| 2018-12-31 | $153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-13 | $101.54M derived: sum of 2 quarters · filed 2020-02-13 | $101.35M 10-Q · filed 2020-02-13 | $101.35M derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-09-30 | $101.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-12 | $101.20M 10-Q · filed 2019-11-12 | $101.20M derived: sum of 3 quarters · filed 2020-06-03 | $101.20M derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-06-30 | -$195.00K 10-Q · filed 2019-08-14 | -$195.00K derived: sum of 2 quarters · filed 2020-06-03 | -$195.00K derived: sum of 3 quarters · filed 2020-06-03 | |
| 2018-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | $0.00 derived: sum of 2 quarters · filed 2020-06-03 | $54.75M 10-K · filed 2020-06-03 | |
| 2017-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | $54.75M 10-Q · filed 2019-02-14 | ||
| 2017-09-30 | $54.75M 10-Q · filed 2018-11-14 | |||
| 2017-03-31 | $15.00M 10-K · filed 2019-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |